Array BioPharma beats by $0.01, misses on revenue

• Array BioPharma (NASDAQ:ARRY-OLD): FQ1 EPS of -$0.21 beats by $0.01.
• Revenue of $6.06M (-57.4% Y/Y) misses by $0.29M.
• Press Release